Source: The Microbe. Unidades: FCF, ICB
Subjects: MICROBIOLOGIA, CANDIDA ALBICANS, ANTIFÚNGICOS, MEMBRANA PLASMÁTICA, PAREDE CELULAR VEGETAL, MORFOGÊNESE, FUNGICIDAS, CANDIDA, VIRULÊNCIA
ABNT
BARROSO, Vinícius de Morais et al. 2-aryloxazolines inhibit Candida clinical isolates growth and morphogenesis of Candida albicans and Candida tropicalis. The Microbe, v. 3, p. 1-11 art. 100062, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.microb.2024.100062. Acesso em: 10 nov. 2025.APA
Barroso, V. de M., Reis, J. S., Stefani, H. A., & Ishida, K. (2024). 2-aryloxazolines inhibit Candida clinical isolates growth and morphogenesis of Candida albicans and Candida tropicalis. The Microbe, 3, 1-11 art. 100062. doi:10.1016/j.microb.2024.100062NLM
Barroso V de M, Reis JS, Stefani HA, Ishida K. 2-aryloxazolines inhibit Candida clinical isolates growth and morphogenesis of Candida albicans and Candida tropicalis [Internet]. The Microbe. 2024 ; 3 1-11 art. 100062.[citado 2025 nov. 10 ] Available from: https://doi.org/10.1016/j.microb.2024.100062Vancouver
Barroso V de M, Reis JS, Stefani HA, Ishida K. 2-aryloxazolines inhibit Candida clinical isolates growth and morphogenesis of Candida albicans and Candida tropicalis [Internet]. The Microbe. 2024 ; 3 1-11 art. 100062.[citado 2025 nov. 10 ] Available from: https://doi.org/10.1016/j.microb.2024.100062
